Investigators reported HEAL‑Surv as a two‑stage, supervised system that leverages multiple molecular and imaging modalities during training to enable pared‑down inference later. The team built an additive Cox teacher that ingests four data streams — clinical variables, molecular profiles, DNA methylation, and imaging mass cytometry (IMC) — to estimate five‑year disease‑specific survival (DSS). A separate student model was optimized to predict survival at inference time using fewer inputs; it learned from both observed outcomes and cross‑fitted survival curves produced by the teacher. The authors noted that student targets were weighted more heavily when survival estimates agreed across random initialisations during cross‑fitting.
The authors designed a hierarchical graph encoder for IMC to represent cellular neighbourhoods and coarser tissue organisation. This encoder captures local cell‑cell relationships, then aggregates to represent larger tissue structures, allowing the teacher to exploit spatial biology alongside molecular signals. The paper described this architecture conceptually; the source did not provide every implementation detail in the abstract, so some encoder hyperparameters and exact graph construction steps were not reported there. The study team argued the hierarchical representation enables the model to use high‑dimensional IMC features without requiring IMC at inference for student deployment.
In five‑fold cross‑validation on 423 METABRIC patients, the full teacher model achieved a mean five‑year Uno’s concordance of 0.723, investigators reported. The source stated that removing any single modality from the teacher reduced mean concordance and increased mean Brier‑based errors, indicating that each modality contributed to discrimination and calibration. The authors provided both concordance and Brier metrics as primary performance indicators, and they used cross‑validation to estimate internal generalisability within METABRIC.
The study team compared a student trained on observed outcomes alone with a distilled student that learned from the teacher’s cross‑fitted survival curves in addition to observed outcomes. Distillation increased the mean five‑year Uno’s concordance from 0.658 for the outcome‑only student to 0.704 for the distilled student. The authors also reported higher integrated and five‑year Brier performance for the distilled student, suggesting improved calibration and discrimination when supervised by the multimodal teacher. These results indicate that multimodal supervision can transfer predictive signal into models that require fewer inputs at deployment.
Investigators evaluated an IMC‑clinical variant trained on METABRIC directly on an external Basel cohort of 265 patients without refitting. The model achieved a five‑year Uno’s concordance of 0.660 on the Basel dataset. The source reported this external result to illustrate out‑of‑sample discrimination when one of the multimodal inputs (for example, DNA methylation or some molecular features) may be absent in the target cohort. The authors stressed that while the teacher benefits from all modalities during training, student models still require independent external validation.
All input datasets were previously published and publicly available. The authors used METABRIC clinical, molecular and DNA methylation releases as well as two IMC cohorts (METABRIC IMC and the Basel IMC cohort), with data links provided in the original manuscript. No new data were collected for this study. The authors declared that relevant ethical approvals and participant consent statements associated with the source cohorts were followed and reported. They also declared no competing interests. Code availability and full implementation details were referenced in the source; interested readers should consult the manuscript and linked repositories for reproducibility materials.
The authors noted that external validation of the student remains necessary. The source explicitly reported an external test for one IMC‑clinical variant but did not claim broad prospective clinical readiness or regulatory clearance. The abstract did not report prospective deployment outcomes, patient‑level calibration plots, nor detailed encoder hyperparameters in full; those specifics were left to the full manuscript and accompanying code. Remaining unanswered questions documented in the source include the extent to which distilled students generalise across additional independent cohorts and how performance varies when particular modalities are systematically missing at inference.